Ralect 0.5 Tablet contains 0.5 mg of Rasagiline as its active ingredient.

Indications: Ralect is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's diseaseas initial monotherapy and as adjunct therapy to dopamine agonists or to levodopa.  

Dosage and Administration:

• Monotherapy: The recommended dose is 1 mg orally once daily. Some sources indicate a starting dose of 0.5 mg once daily, which may be increased to 1 mg once daily if needed.
• Adjunct therapy (without Levodopa): The recommended dose is 1 mg once daily.
• Adjunct therapy (with Levodopa): The recommended initial dose is 0.5 mg once daily. If tolerated and a sufficient response isn't achieved, it may be increased to 1 mg once daily. A reduction of the levodopa dose may be considered based on individual response.

Ralect can be taken with or without food. Follow your doctor's instructions carefully.

Side Effects: Common side effects may include:

• Dizziness
• Spinning sensation
• Joint pain
• Headache
• Heartburn
• Nausea
• Muscle pain
• Insomnia (difficulty sleeping)
• Indigestion
• Flu-like symptoms
• Depression
• Cough
• Peripheral edema

Precautions:

• Concomitant use with meperidine, tramadol, methadone, propoxyphene, and MAO inhibitors (including other selective MAO-B inhibitors) is contraindicated due to the risk of serotonin syndrome.
• Use with caution with dextromethorphan and antidepressants.
• May exacerbate hypertension; blood pressure should be monitored.
• Use with caution in patients with mild hepatic impairment, and the dose should not exceed 0.5 mg once daily if taking concomitant Ciprofloxacin or other CYP1A2 inhibitors.
• Exercise caution in patients with a history of skin cancer.
• Be cautious while driving or doing anything that requires concentration as Ralect may cause dizziness or sleepiness.
• Avoid sudden discontinuation of the medication.
• As a precaution, avoid foods high in tyramine (e.g., aged cheeses, air-dried meat, soy sauce, tap/draft beer).
• Inform your doctor if you experience any unusual changes in mood, hallucinations, or compulsive behaviors.

Pregnancy and Lactation: Ralect should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus (Pregnancy Category C). Caution should be exercised when²administering to a breastfeeding woman.

Storage: Store below 30°C, protected from light and moisture. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication.